These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 200373)

  • 1. [Epidemiology of Hodgkin's disease].
    Holý J; Hrodek O; Hynieová H; Srajer J
    Cesk Pediatr; 1977 Jul; 32(7):414-7. PubMed ID: 200373
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of Epstein-Barr virus antibodies in Hodgkin's disease].
    Vanĕcek K; Holý J; Hrodek O; Hynieová H; Petrtýlová K; Srajer J
    Cesk Pediatr; 1981 Aug; 36(8):449-52. PubMed ID: 6268310
    [No Abstract]   [Full Text] [Related]  

  • 3. Discussion of case-control study of Hodgkin's disease.
    Newell GR; Henderson BE
    Cancer Res; 1974 May; 34(5):1169-71. PubMed ID: 4366988
    [No Abstract]   [Full Text] [Related]  

  • 4. [Herpesvirus antibodies in Hodgkin's disease and some lympho-hematopoietic diseases in children and adolescents].
    Holý J; Hrodek O; Hynieová H; Srajer J
    Cesk Pediatr; 1977 Apr; 32(4):216-21. PubMed ID: 194715
    [No Abstract]   [Full Text] [Related]  

  • 5. Expression of Epstein-Barr virus in classical Hodgkin's lymphomas in Brazilian adult patients.
    Vassallo J; Metze K; Traina F; de Souza CA; Lorand-Metze I
    Haematologica; 2001 Nov; 86(11):1227-8. PubMed ID: 11694413
    [No Abstract]   [Full Text] [Related]  

  • 6. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Hodgkin's disease.
    Gutensohn N; Cole P
    Semin Oncol; 1980 Jun; 7(2):92-102. PubMed ID: 6255608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epstein-Barr virus in the environment of patients with Hodgkin's disease].
    Vanĕcek K; Holý J
    Cesk Pediatr; 1981; 36(1):12-5. PubMed ID: 6258815
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic changes in patients with Hodgkin's disease in clinical remission and recurrence].
    Ares BR; Sasiain MD; Brezavscek DM; Fejes M; Bachmann AE
    Medicina (B Aires); 1981; 41(3):287-92. PubMed ID: 6275237
    [No Abstract]   [Full Text] [Related]  

  • 11. [Epstein-Barr virus capsid antigen (EB-VAC)-IgA antibody titer in splenectomized patients with Hodgkin's disease. A follow-up study].
    Gunzer U; Nürnberger R
    Verh Dtsch Ges Inn Med; 1974; 80():1619-23. PubMed ID: 4375897
    [No Abstract]   [Full Text] [Related]  

  • 12. Infective agents in the causation of Hodgkin's disease. A review of the epidemiological evidence.
    Abramson JH
    Isr J Med Sci; 1973 Jul; 9(7):932-53. PubMed ID: 4354626
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus-related serology in Hodgkin's disease.
    Henle W; Henle G
    Natl Cancer Inst Monogr; 1973 May; 36():79-84. PubMed ID: 4355353
    [No Abstract]   [Full Text] [Related]  

  • 14. [Virus etiology of Hodgkin's disease].
    Gassmann W; Schmitz N; Löffler H
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1171-2. PubMed ID: 6286265
    [No Abstract]   [Full Text] [Related]  

  • 15. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.
    Weinreb M; Day PJ; Murray PG; Raafat F; Crocker J; Parkes SE; Coad NA; Jones JT; Mann JR
    J Pathol; 1992 Dec; 168(4):365-9. PubMed ID: 1336543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of Hodgkin's disease. II. Herpesvirus group antibody titers and HL-A type.
    Henderson BE; Dworsky R; Menck H; Alena B; Henle W; Henle G; Terasaki P; Newell GR; Rawlings W; Kinnear BK
    J Natl Cancer Inst; 1973 Nov; 51(5):1443-7. PubMed ID: 4357759
    [No Abstract]   [Full Text] [Related]  

  • 17. [Seroepidemiologic studies in lymphogranulomatosis].
    Kokosha LV; Lapin BA; Lebedev VN; Danilova NV; Arshba NN
    Probl Gematol Pereliv Krovi; 1981 Aug; 26(8):12-6. PubMed ID: 6272267
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibodies against herpesviruses in patients with Hodgkin's disease.
    Wutzler P; Färber I; Sprössig M; Sauerbrei A; Wutke K; Höche D; Rüdiger KD; Wöckel W; Scheibner K
    Arch Geschwulstforsch; 1983; 53(5):417-22. PubMed ID: 6316868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease.
    Berard CW
    Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349
    [No Abstract]   [Full Text] [Related]  

  • 20. The course and the results of treatment in Hodgkin's disease.
    Durkovský J; Jancina J; Kuzma I
    Neoplasma; 1967; 14(1):91-104. PubMed ID: 6031833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.